Acute Kidney Injury (AKI): Symptoms, Triage & Emergency Red Flags

Acute kidney injury describes a rapid reduction in the kidney’s ability to filter nitrogenous waste, regulate electrolytes, and maintain fluid balance. In most hospitalised adults, teams anchor the diagnosis to a temporal creatinine change against a known or imputed baseline, paired with urine output trends when measurable. Because creatinine is a delayed and imperfect marker, clinical context—hypovolaemia, sepsis, heart failure phenotypes, obstruction, and drug exposures—often precedes obvious laboratory change.

Severity ranges from transient azotaemia that resolves within days to multiorgan syndromes requiring kidney replacement therapy. AKI sits on a continuum with chronic kidney disease: pre‑existing CKD lowers reserve and raises AKI risk, and an AKI episode can leave a sustained decrement in eGFR even after creatinine normalises. That bidirectional risk makes follow-up after hospital discharge as important as the inpatient rescue phase.

KDIGO staging stratifies AKI after the syndrome is present. Higher stages should trigger tighter nursing observations, more frequent blood tests, pharmacy review, and earlier nephrology or critical care dialogue. Urine-output staging requires a reliable weight estimate and duration of oliguria; patients on loop diuretics may not fulfil urine criteria despite tubular injury.

↔On a small screen, swipe or scroll sideways to see the full table.

Units and screening rules differ worldwide; tie thresholds to local laboratory reporting and AKI e‑alert algorithms (for example UK versus North American documentation traditions).

AKI is often silent while still leaving objective clues in urine output, daily weights, and blood tests. When patients do declare symptoms, the pattern overlaps many ward problems—so a low threshold to compare new fatigue, nausea, or breathlessness against baseline renal function supports earlier detection.

Typical features

• Reduced urine volume or abrupt change in voiding pattern (track urinary output measurement carefully when catheters are present).
• Fluid retention: peripheral oedema, weight gain, or pulmonary congestion overlapping with heart failure flares.
• Nonspecific malaise, anorexia, or metallic taste as azotaemia deepens.

Atypical or high‑risk presentations

• Elderly patients, those with CKD, or malnourished adults may show minimal oliguria despite significant creatinine movement.
• Postoperative patients may attribute symptoms to analgesia or anaesthesia rather than emerging AKI.
• Obstructive uropathy may present with suprapubic discomfort or paradoxical polyuria after partial relief.

Mechanistic labels help teams choose reversible treatments. Prerenal states reflect renal hypoperfusion; intrinsic renal injury includes ischaemic or toxic tubular damage, glomerular inflammation, and interstitial nephritis; postrenal injury reflects outflow obstruction at any level from urethra to ureteric orifices. Many real patients blend categories—sepsis with hypovolaemia plus antibiotics is a common example.

Modifiable or situational risk

• Hypovolaemia, bleeding, or over‑diuresis: balance furosemide against measurable response.
• Nephrotoxins: aminoglycosides, vancomycin, contrast exposure, and ibuprofen or other NSAIDs.
• HAART, chemotherapy, or tumour lysis protocols—coordinate timing of labs with prescribing teams.

Structural baseline risk

• Chronic kidney disease, older age, diabetes mellitus, and heart failure reduce functional reserve.
• Acute coronary syndrome or major surgery raises ischaemic and inflammatory kidney stress.
• Kidney stones, malignancy, or prostate pathology predispose to obstructive AKI.

Clinical assessment

Assess volume status with orthostatic vitals when safe, mucous membranes, JVP if trained, drains/losses, and stool frequency. Review the medication administration record for recent contrast, NSAIDs, ACE inhibitors, diuretics, and antimicrobials. Examine for a distended bladder or flank pain raising stone or obstruction suspicion.

Laboratory investigations

• Serial serum creatinine with explicit baseline comparison; add BUN ratio patterns only as supportive data (high protein catabolism and GI bleeding also elevate urea).
• Electrolytes, glucose, venous or arterial blood gas when acid–base disturbance is suspected.
• C-reactive protein or procalcitonin where your sepsis pathway uses biomarkers—interpret as an adjunct to cultures, not a stand‑in for clinical examination.
• Fractional excretion indices when free water handling questions persist (interpret cautiously on diuretics; some units prefer FE_Urea).

Imaging

Renal tract ultrasound is first-line for suspected obstruction when feasible. Contrast CT is reserved for selected cases after risk stratification; do not delay emergent imaging if non-contrast alternatives cannot answer a life-threatening question.

Diagnostic criteria used in practice

KDIGO creatinine and urine output thresholds above define AKI for most quality metrics and e‑alerts; your institution may layer early warning scores or biomarker pathways as evidence evolves.

Not every creatinine rise is “medical AKI”—misclassified urinary retention, laboratory interference, or uncorrected dehydration can mimic intrinsic injury. Use the table to triage within minutes at the bedside, then refine with labs.

↔On a small screen, swipe or scroll sideways to see the full table.

1. Detect: Trigger AKI protocols on creatinine deltas, new hyperkalaemia, or sustained oliguria.
2. Stabilise perfusion: Treat shock per sepsis bundles where relevant; give crystalloid boluses only when volume depletion is likely, reassessing lung and perfusion endpoints each time.
3. Rule out obstruction: Bladder scan or catheter assessment before repeated fluid alone.
4. Interrogate medicines: Hold or adjust nephrotoxins in partnership with prescriber; eye metformin during sick-day risk.
5. Monitor: Pair intake/output charts with daily weights; schedule repeat labs based on severity (often 6–24 h windows for stage ≥2).
6. Escalate: Call nephrology or critical care when stage 3 criteria, refractory K⁺, pulmonary oedema, or falling consciousness coincide with azotaemia.

First-line, mechanism-targeted care

• Treat infection sources, bleeding, and cardiogenic components of shock—sepsis bundles and inotrope plans belong to senior-led order sets.
• Relieve obstruction with catheter, stent, or surgical decompression as indicated.
• Use balanced crystalloids for expansion where guidelines recommend them; avoid starch colloids for renal risk contexts.

Electrolyte and acid–base rescue

• Hyperkalaemia: IV calcium when ECG changes, insulin/glucose shift with monitoring, potassium binders per protocol, nebulised salbutamol adjunct—repeat gases frequently. Titrate supplemental oxygen if pulmonary oedema coexists.
• Acidosis: bicarbonate only under defined thresholds and senior direction; prepare for dialysis if refractory.

Kidney replacement therapy (KRT)

Indications align broadly with refractory metabolic derangement, uraemic complications, and fluid overload failing medical therapy—exact modality (intermittent haemodialysis, sustained low-efficiency treatment, or CRRT) is critical care or nephrology choice.

Special populations

Pregnancy, cirrhosis with hepatorenal physiology, and haemodynamic-dependent heart failure often need MDT input before large fluid shifts. Children require weight-based calculations; do not extrapolate adult bolus volumes.

• Monitoring cadence: Stage 1 AKI often warrants daily creatinine/electrolytes unless improving; stage 2–3 typically needs ≤24 h intervals and tighter vital surveillance.
• Medicines: Pharmacy review for renally cleared drugs; coordinated pausing of ACE inhibitors/ARBs during acute instability with a documented restart plan.
• Fluids: Reassess after each bolus—listen for crackles, watch SpO₂, and trend lactate where used.
• Documentation: Record baseline creatinine sources, obstruction assessments, family discussion points about dialysis, and exact escalation times.
• Referral: Nephrology for diagnostic uncertainty, glomerular suspicion, persistent stage 3, or anticipated chronic dialysis.

• Hyperkalaemia with arrhythmia.
• Pulmonary oedema secondary to sodium and fluid retention.
• Uraemic bleeding diathesis or platelet dysfunction.
• Transition to dialysis dependence or accelerated CKD.
• Increased late cardiovascular events after hospital discharge.

Bundle preventive habits into every high-risk admission: maintain euvolaemia when possible, time contrast studies with protocols, avoid stacking nephrotoxins, and reconcile NSAID use in patients already on ACE inhibitors/ARBs and diuretics. Early recognition of sepsis and rapid source control outperform late rescue dialysis.

Mild, quickly reversed AKI often leaves minimal residual deficit, while repeated episodes or prolonged need for kidney replacement herald higher CKD progression. Communicate uncertainty honestly: renal recovery can lag creatinine decline, and some patients plateau at a new lower eGFR requiring primary-care monitoring.

• When a patient “looks dry” but has crackles, involve seniors before repeat boluses—this is often cardiorenal overlap rather than simple dehydration.
• Always verify catheter patency before charting anuria; clot or kink generates false crisis.
• Teach night teams the overnight handoff pearl: trending creatinine beats single-point values; highlight deltas in handover to protect sleep-shift cognition.

• Outputs: Hourly or block totals; colour; presence of sediment or myoglobin suspicion.
• Haemodynamics: MAP targets per condition; vasopressor infusions; temperature curve in infection.
• Respiratory: Work of breathing, SpO₂, new oxygen requirement suggesting fluid overload.
• Access / devices: Patent intravenous lines for emergent calcium or insulin infusions.
• Laboratory: Potassium, bicarbonate, glucose (after insulin shift), calcium when ECG changes.

• Anuria beyond documented catheter issues with rising creatinine.
• Hyperkalaemia with ECG change or critical laboratory value per local policy.
• Severe confusion plus rapidly accelerating azotaemia.
• Haemodynamic collapse where AKI may be part of a shock syndrome.

Objective triggers for senior review include falling Glasgow Coma Scale, escalating lactate, rising potassium despite protocol therapy, urine output persistently <0.3 mL/kg/h after optimisation, or SpO₂ drop on minimal exertion due to pulmonary congestion. Activate emergency teams when vital sign criteria for your rapid response are met—document medicines given and response time.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze drops on the topic of KDIGO-staged AKI, prerenal vs intrinsic vs postrenal differentiation, hyperkalaemia management and the AEIOU indications for renal replacement therapy.